Genomics is the study of the structure, function, evolution and mapping of genomes
Main goals of the Human Genome Project:
Provide a complete and accurate sequence of the 3 billion DNA base pairs in the human genome
Identify all genes in the human genome and find the location of each gene
The Human Genome Project aimed to:
Help understand diseases to improve diagnosis and treatment
Identify mutations linked to different forms of cancer
Improve medication design
More accurately predict the effects of drugs
Improve disease risk assessment
Advance forensic applied sciences
Use in bioarcheology, anthropology, and evolution
Sanger Sequencing:
Initially, the process took a long time and focused on a small number of DNA samples
The first human genome took 13 years to prepare (approx. 3 billion bases) using this technique
Next Generation Sequencers (NGS):
NGS are modern versions of Sanger Sequencing, producing a base sequence for a whole organism in a few hours
Several methods of NGS add labelled bases to a growing chain of nucleotides, many of which can be analyzed simultaneously
NGS is significantly cheaper, quicker, needs less DNA, and is more accurate and reliable than Sanger sequencing
In Sanger sequencing, a large amount of template DNA is needed for each read, while in NGS, a sequence can be obtained from a single strand
NGS is quicker than Sanger sequencing because the chemical reaction is combined with the sequencing, unlike in Sanger sequencing where these are two separate processes
In Sanger sequencing, a maximum of ~1kb can be analyzed at a time, whereas in NGS, about 300Gb of DNA can be sequenced in the same run
NGS is more automated, uses fewer resources, is faster, and costs less compared to Sanger sequencing
The first human genome sequence cost around £300 million, while using modern Sanger sequencing methods, a full human genome would still cost £6 million. Sequencing a human genome with NGS today would cost only £6,000
The 100K Genome Project aims to sequence the DNA of 100,000 people in the UK
NGS technology enables the 100K Genome Project to reduce cost and time in sequencing DNA
The project will allow scientists to study variation in the human genome
The 100K Genome Project focuses on diseases like rare cancers
Unlike the Human Genome Project, data in the 100K Genome Project is not anonymous; participants give informed consent for the use of their data
Aims of the 100K Genome Project include:
Improve the accuracy of diagnoses
Better predict the action of drugs
Improve the design of drugs
Find new ways of treating genetic diseases
Explore tailoring therapies to treat a disease in an individual person
Genetic screening can now identify a large number of defective genes
Genes like Alzheimer’s disease, Huntington’s Chorea, and certain cancers may only manifest their effects in adults
Screening for genes like these could help doctors prepare for future issues and allow patients to plan ahead, especially for conditions with no treatments and are fatal
Concerns exist regarding discrimination and social stigmatization outweighing the benefits of genetic testing
There is a fear that insurance companies and some businesses might discriminate against individuals based on their genotype, affecting employment and insurance opportunities
Advantages of genetic screening following the Human Genome Project:
Can identify carriers of genetic disease
Provides genetic counselling
Screens embryos prior to implantation
Assesses future risk of developing a condition
Checks a foetus during pregnancy to detect disorders like cystic fibrosis, Huntington’s disease, and thalassaemia
Disadvantages of genetic screening following the Human Genome Project:
Not always accurate
No cure for most conditions, causing stress for gene carriers
Misuse of personal genetic information by entities like insurance companies, private health care, and employers leading to discrimination
Risk of stigmatization for individuals with identified genes
Concerns about routine screening for adult-onset disorders like Alzheimer’s disease and some cancers
Potential use to select embryos for non-medical purposes, such as specific characteristics
Sequencing the genome of chimpanzees and other primates helps determine evolutionary relationships between primate groups and aids in conservation efforts
Malaria, caused by the protoctistan parasite Plasmodium and transmitted by the mosquito Anopheles gambiae, is one of the biggest killers globally
The genome of Anopheles gambiae has been sequenced to control malaria, as it is the vector that transmits the Plasmodium parasite to humans
Control of mosquito populations, crucial in managing malaria spread, has been achieved by using insecticides, but many mosquitoes are now resistant
Sequencing the mosquito genome aims to edit out resistance genes, potentially rendering male mosquitoes sterile to reduce populations in malarial areas
One ethical concern is the potential ecological impact of rendering mosquitoes sterile, affecting organisms dependent on mosquitoes for food and potentially leading to mosquito extinction
Mosquitoes are vectors of diseases like the Zika virus, so controlling their population can help manage the spread of mosquito-vectored diseases
The Plasmodium parasite causing malaria has also been sequenced to develop effective drug treatments, as resistance to traditional chloroquine drugs is spreading rapidly
Artemisinin drugs are being used in combination with others to combat malaria resistance, and sequencing the Plasmodium genome aims to render the parasite susceptible to drug treatments
Each human (apart from identical twins) contains a unique sequence of bases in their genome, known as a "genetic fingerprint," which can be used in forensic science and paternity testing
A gene is composed of regions that are translated – exons and introns, with repeating base sequences between exons that are not translated
The number of repeats of base sequences in introns, called short tandem repeats or STRs, is variable between individuals
In a genetic fingerprint, a variety of these STRs are analyzed to produce a unique pattern based on the number of times each STR is repeated
Forensics use the characteristic pattern of bands in genetic fingerprints to identify individuals from sample materials, such as victims and suspects, requiring an exact match of banding patterns for identification
DNA samples for genetic fingerprinting could be from sperm cells, white blood cells from blood smears, skin cells, or hair follicles, sometimes requiring amplification for analysis
In paternity cases, the technique relies on the fact that the STRs are inherited, with a child inheriting some bands from its biological father and some from its mother
Markers of known length run alongside the fingerprint DNA to provide fragment size and position, forming a DNA ladder